# Mount Sinai Hospital Blood Bank – FDA Inspection, Jul 2, 2024

Source: https://www.keypedia.com/records/fda_inspections/mount-sinai-hospital-blood-bank/eab97864-0a8d-4393-8ecc-64033c7007ad
Source feed: FDA_Inspections

> FDA inspection 1243297 of Mount Sinai Hospital Blood Bank, July 02, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 606. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1243297
- Company Name: Mount Sinai Hospital Blood Bank
- Inspection Date: 2024-07-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1323324 - 2026-06-08
- FDA Inspection 1168200 - 2022-04-13
- FDA Inspection 1046035 - 2018-01-24
- FDA Inspection 950522 - 2015-11-19
- FDA Inspection 889365 - 2014-07-28

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/mount-sinai-hospital-blood-bank/fa7a51f0-6f38-4f03-8a70-bcb59fb35f2b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d